The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Vaccine Safety Forum: Summaries of Two Workshops
Urnovitz HB, Murphy WH. Human endogenous retroviruses: Nature, occurrence and clinical implications in human disease. Clinical Microbiology Reviews 1996; 9:72–99.
Urnovitz HB, Murphy WH, Gottfried TD, and Friedman-Kien, AE. Urine-based diagnostic technologies. Trends in Biotechnology 1996; 14:361–364.
Ventura SJ, Martin JA, Mathews TJ, et al. Advance report of final natality statistics, 1994. Monthly vital statistics report; 44(11) Suppl. Hyattsville, Md.: National Center for Health Statistics, 1996.
Vergelli M, Hemmer B, Utz U, et al. Differential activation of human autoreactive T-cell clones by altered peptide ligands derived from myelin basic protein peptide (87–99). European Journal of Immunology 1996; 26:2624–2634.
Vogt AB, Kropshofer H, Kalbacher H, et al. Ligand motifs of HLS-DRB5 *0101 and DRBI*1501 molecules delineated from self-peptides. Journal of Experimental Medicine 1994; 153:1665–1673.
Waisbren BA. Other side of the coin (letter). Infectious Disease News 1992; 5:2.
Warkany J. Congenital Anomalies: Notes and Comments. Chicago: Year Book Medical Publishers , 1971.
Westall FC, Root-Bernstein RS. An explanation of prevention and suppression of experimental allergic encephalomyelitis. Molecular Immunology 1983; 20:169–177.
White CS, Adler WH, McGann VG. Repeated immunization: Possible adverse effects. Reevaluation of human subjects at 25 years. Annals of Internal Medicine 1974; 81:594–600.
Wucherpfennig KW, Wette A, Southwood S, et al. Structural requirements for the binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T-cell clones. Journal of Experimental Medicine 1994; 179;279–290.
Zhang J, Markovic S, Lacet B, et al. Increased frequency of IL2 responsive T-cells specific for myelin basic protein and preteolipid protein in peripheral blood and cerebrospinal fluid of patients with Multiple sclerosis. Journal of Experimental Medicine 1994; 179:973–984.